ABEL GUTIERREZ: Open Payments
NPI 1932942745 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,868 in 83 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $887 · 2025 $1,868
Food & beverage: $1,868
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $256 |
| Xeris Pharmaceuticals, Inc. | 7 | $246 |
| ABIOMED | 5 | $229 |
| ABBVIE INC. | 9 | $209 |
| PFIZER INC. | 3 | $171 |
| Lilly USA, LLC | 13 | $146 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| Viatris Specialty LLC | 3 | $56 |
| Verity Pharmaceuticals Inc. | 3 | $52 |
Products named: RECORLEV, MOUNJARO, ZAVZPRET, Ozempic, QULIPTA, Auvelity, VRAYLAR, Wegovy.
Industry payments across CA — which companies pay providers there.
